Literature DB >> 1379086

Interleukin-2-activated natural killer cells can support hematopoiesis in vitro and promote marrow engraftment in vivo.

W J Murphy1, J R Keller, C L Harrison, H A Young, D L Longo.   

Abstract

Purified natural killer (NK) cells were obtained from mice with severe combined immune deficiency (SCID) to ascertain their effect on hematopoiesis. When activated and propagated with recombinant human interleukin-2 (rhIL-2) in vitro, SCID spleen cells maintained a phenotypic and lytic spectrum consistent with a pure population of activated NK cells. When added with syngeneic bone marrow cells (BMC) in soft agar, the activated NK cells could support hematopoietic growth in vitro without the addition of exogenous hematopoietic growth factors. However, when syngeneic BMC were added along with cytokines to produce optimal growth conditions, the addition of NK cells was then inhibitory for hematopoietic colony formation. Antibodies to interferon-gamma (IFN-gamma) partially reversed the inhibitory effects. Supernatants from the NK-cell cultures could also exert these effects on hematopoiesis, although to a lesser extent. Analysis of the NK cell RNA demonstrated that activated NK cells express genes for hematopoietic growth factors such as granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte CSF (G-CSF), and IL-1 beta. The NK cells were also found to express IFN-gamma, transforming growth factor-beta 1 (TGF-beta 1), and tumor necrosis factor-alpha (TNF-alpha) mRNA. Analysis of the NK-cell supernatants using factor-dependent myeloid progenitor cell lines showed that the NK cells were producing G-CSF and growth-promoting activity that could not be attributed to IL-1, IL-3, IL-4, IL-5, IL-6, GM-CSF, G-CSF, macrophage CSF (M-CSF), or stem cell factor. The transfer of activated NK cells with BMC into lethally irradiated syngeneic mice resulted in greater BMC engraftment in the recipients. Thus, these results using a pure population of activated NK cells indicate that when activated, these cells can produce a variety of growth factors for hematopoiesis and exert significant hematopoietic growth-promoting effects in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379086

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells.

Authors:  Isabel Barao; Alan M Hanash; William Hallett; Lisbeth A Welniak; Kai Sun; Doug Redelman; Bruce R Blazar; Robert B Levy; William J Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

2.  Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.

Authors:  O Asai; D L Longo; Z G Tian; R L Hornung; D D Taub; F W Ruscetti; W J Murphy
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

Review 3.  Natural killer (NK) cells in antibacterial innate immunity: angels or devils?

Authors:  Fernando Souza-Fonseca-Guimaraes; Minou Adib-Conquy; Jean-Marc Cavaillon
Journal:  Mol Med       Date:  2012-03-30       Impact factor: 6.354

Review 4.  Cellular engineering and therapy in combination with cord blood allografting in pediatric recipients.

Authors:  M S Cairo; N Tarek; D A Lee; C Delaney
Journal:  Bone Marrow Transplant       Date:  2015-09-14       Impact factor: 5.483

5.  Tissue-specific homing and expansion of donor NK cells in allogeneic bone marrow transplantation.

Authors:  Janelle A Olson; Robert Zeiser; Andreas Beilhack; Joshua J Goldman; Robert S Negrin
Journal:  J Immunol       Date:  2009-08-05       Impact factor: 5.422

6.  Potential role of natural killer cells in controlling tumorigenesis by human T-cell leukemia viruses.

Authors:  G Feuer; S A Stewart; S M Baird; F Lee; R Feuer; I S Chen
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

7.  Primary occult hepadnavirus infection induces virus-specific T-cell and aberrant cytokine responses in the absence of antiviral antibody reactivity in the Woodchuck model of hepatitis B virus infection.

Authors:  Shashi A Gujar; Tomasz I Michalak
Journal:  J Virol       Date:  2009-02-04       Impact factor: 5.103

8.  Immunomodulatory Effect of Rhaphidophora korthalsii on Natural Killer Cell Cytotoxicity.

Authors:  Swee Keong Yeap; Abdul Rahman Omar; Abdul Manaf Ali; Wan Yong Ho; Boon Kee Beh; Noorjahan Banu Alitheen
Journal:  Evid Based Complement Alternat Med       Date:  2011-09-15       Impact factor: 2.629

Review 9.  Therapeutic use of Aldara in chronic myeloid leukemia.

Authors:  Annette M Marleau; Jeffrey H Lipton; Neil H Riordan; Thomas E Ichim
Journal:  J Transl Med       Date:  2007-01-25       Impact factor: 5.531

Review 10.  Immunological Basis of Bone Marrow Failure after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Stavroula Masouridi-Levrat; Federico Simonetta; Yves Chalandon
Journal:  Front Immunol       Date:  2016-09-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.